Leiomyosarcoma Cancer from Diagnosis to Treatment


What is Leiomyosarcoma?

Leiomyosarcoma is a rare and aggressive cancer that starts in smooth muscle tissue - the type of muscle found in the walls of organs, blood vessels, and skin.

Most common in:
Uterus
Abdomen or retroperitoneum
Arms and legs | soft tissues
Blood vessel walls

Leiomyosarcoma is a malignant soft-tissue sarcoma that tends to grow quickly and may spread through the bloodstream, often to the lungs or liver.


1. Initial Evaluation

Medical History & Physical Exam:
The doctor checks for symptoms such as a firm lump, abdominal swelling, pain, unexplained bleeding | for uterine LMS |, or weight loss.

Clinical suspicion:
A deep, enlarging, or painful mass that does not move easily under the skin often raises suspicion for sarcoma.


2. Imaging and Scanning Tests

Ultrasound
Often the first imaging test.
Detects the presence of a solid mass and guides biopsy if needed.

Magnetic Resonance Imaging
The preferred test for tumors in soft tissues of the arms, legs, or pelvis.
Provides detailed images showing the tumor’s size, borders, and involvement with nearby structures.

CT Scan
Main imaging tool for abdominal or retroperitoneal leiomyosarcomas.
Shows organ involvement and possible metastasis.

Chest CT Scan
Used to check for lung metastases, since LMS commonly spreads to the lungs.

PET-CT
May be done to find active or hidden metastases throughout the body and assess tumor metabolism.


3. Biopsy and Pathology

Core Needle Biopsy
A thin needle removes small tissue samples under local anesthesia or image guidance.

Incisional Biopsy
Performed if a larger sample is needed for accurate diagnosis.

Histopathological Examination
Under the microscope, the tumor cells appear spindle-shaped | elongated - typical of smooth muscle origin.
Special stains like SMA, Desmin, and h-caldesmon confirm smooth muscle differentiation.

Molecular Tests
Genetic testing may help rule out other sarcoma types or identify mutations for targeted therapy.


4. Staging
Staging helps doctors understand how far the cancer has spread.

I - Low-grade, localized tumor
II - Larger or intermediate-grade tumor
III - High-grade or locally advanced
IV - Cancer has spread to distant organs


5. Treatment Options

Surgery

The goal is complete removal of the tumor with wide margins of healthy tissue.

For uterine LMS:
Total hysterectomy | removal of uterus - sometimes with ovaries and fallopian tubes.

For retroperitoneal or extremity LMS:
Surgery may involve removing nearby affected organs or tissues.

If full removal is not possible, debulking surgery can reduce tumor burden and relieve symptoms.

Radiation Therapy

Preoperative:
Shrinks tumor before surgery.

Postoperative:
Kills remaining cancer cells to reduce recurrence.

External Beam Radiation Therapy is most common - delivered precisely to minimize damage to healthy tissues.

Chemotherapy

Used for:
High-grade or metastatic LMS
Uterine LMS, which often spreads early
Inoperable cases

Common drugs:
Doxorubicin
Ifosfamide
Gemcitabine + Docetaxel
Dacarbazine
Trabectedin

Neoadjuvant:
Before surgery to shrink tumor

Adjuvant:
After surgery to prevent recurrence

Palliative:
To slow advanced disease

Targeted Therapy & Immunotherapy

Trabectedin and Eribulin:
Used for advanced or recurrent cases.

Pazopanib | Votrient
A targeted drug used in some soft tissue sarcomas.

Immunotherapy:
Currently under research, showing promise in certain LMS cases.


6. Supportive and Rehabilitation Care

Physical therapy:
Restores movement and strength after surgery.

Pain management:
Controls discomfort during treatment and recovery.

Nutritional support:
Helps maintain strength and healing.

Psychological counseling:
Supports emotional well-being.

Palliative care:
For advanced cases, focuses on comfort and quality of life.


7. Follow-Up Care

After Treatment:
Every 3 months for first 2 years
Every 6 months for next 3 years
Annually after 5 years

Includes:
Physical exam
MRI of original site
Chest CT for metastasis
Annual scans and checkups